Loading
Latest filing published 31 Mar 2025 for GeoVax Labs, Inc., €6,788.
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Mark Reynolds on record concern GeoVax Labs, Inc. We count 18 filings; the first trade dates from 6 December 2007 and the latest from 31 March 2025.
On the market, this insider has only ever bought: 18 purchases, €315k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2025, the count stands at 1 purchase and no sales.
The median purchase comes to €2,675. The 4 purchases reviewed show no overlap with other insiders buying the same stock within a month. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -15.9%. They describe history only and say nothing certain about the share price ahead.
The latest filing, published on 31 March 2025, reports an open-market purchase of €6,788 in GeoVax Labs, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations